Read more about the article Optellum technology can help to determine more cost-effective intervals for lung cancer screening
JAMA Network Open logo

Optellum technology can help to determine more cost-effective intervals for lung cancer screening

A paper published in JAMA Network Open shows the potential for deep learning algorithms to assign individuals to two-year screening intervals, reducing the harm of screening and potentially making screening…

Continue ReadingOptellum technology can help to determine more cost-effective intervals for lung cancer screening

European consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study

A paper published in Lung Cancer demonstrates the ability of Optellum’s Lung Cancer Prediction artificial intelligence (AI) to classify lung nodule malignancy. As discussed in earlier news stories, there has…

Continue ReadingEuropean consortium validates Optellum AI to differentiate between benign and malignant lung nodules in a multi-center study

Optellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal

Global leading doctors from Vanderbilt and Oxford have published independent clinical validation of the Optellum Lung Cancer Prediction AI, illustrating its potential to shorten time to diagnosis. The paper, with…

Continue ReadingOptellum’s lung cancer prediction AI is clinically validated in the top-ranked US respiratory journal